Teratogenesis and other adverse effects on the fetus of antimicrobial drugs used in pregnancy.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000009:adverse effects*; D000962:Antimalarials / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects; D000998:Antiviral Agents / Q000009:adverse effects; D005260:Female; D005333:Fetus / Q000187:drug effects / Q000378:metabolism; D005492:Folic Acid / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000962:Antimalarials; D000995:Antitubercular Agents; D000998:Antiviral Agents; D005492:Folic Acid